Alzamend Neuro (ALZN) Prepaid Assets (2020 - 2026)
Alzamend Neuro's (ALZN) quarterly Prepaid Assets came in at $1.1 million in Q2 2026, up 360.74% year-over-year from $228719.0 in Q2 2025, and up 6.86% quarter-over-quarter from $986143.0 in Q1 2026.
Analysis
Alzamend Neuro (ALZN) Prepaid Assets (2020 - 2026) Analysis & Trends
Alzamend Neuro has disclosed Prepaid Assets across 7 years of filings, most recently posting $1.1 million for Q2 2026.
- In Q2 2026, Prepaid Assets rose 360.74% year-over-year to $1.1 million; the TTM figure through Apr 2026 stood at $1.1 million (up 360.74% YoY), while the FY2026 annual figure was $1.1 million, up 360.74% from the prior year.
- Prepaid Assets came in at $1.1 million for Q2 2026 at Alzamend Neuro, up from $986143.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.1 million in Q2 2026 to a low of $79194.0 in Q2 2024.
- Average Prepaid Assets over 5 years is $518648.2, with a median of $564052.5 recorded in 2023.
- Year-over-year, Prepaid Assets tumbled 82.31% in 2024 and jumped 360.74% in 2026.
- Over 5 years, Prepaid Assets stood at $742001.0 in 2022, then fell by 21.59% to $581802.0 in 2023, then gained by 15.79% to $673669.0 in 2024, then plunged by 59.62% to $272015.0 in 2025, then surged by 287.41% to $1.1 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $1.1 million in Q2 2026, $986143.0 in Q1 2026, and $272015.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.51 Bn | 192.52 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.28 Bn | 176.11 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.06 Bn | 123.21 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.61 Bn | 73.62 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.71 Bn | 55.52 Bn | 1.37 Bn |
| 6 | Moderna | 53.60 Bn | 48.46 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.41 Bn | 30.10 Bn | 992.69 Mn |
| 8 | Biogen | 31.79 Bn | 30.50 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.11 Bn | 29.11 Bn | 1.16 Mn |
| 10 | Alzamend Neuro | 5.57 Mn | 5.57 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 1.05 Mn |
| Jan 31, 2026 | 986,143.00 |
| Oct 31, 2025 | 272,015.00 |
| Jul 31, 2025 | 307,958.00 |
| Apr 30, 2025 | 228,719.00 |
| Jan 31, 2025 | 589,208.00 |
| Oct 31, 2024 | 673,669.00 |
| Jul 31, 2024 | 222,241.00 |
| Apr 30, 2024 | 79,194.00 |
| Jan 31, 2024 | 310,738.00 |
| Oct 31, 2023 | 581,802.00 |
| Jul 31, 2023 | 718,188.00 |
| Apr 30, 2023 | 447,589.00 |
| Jan 31, 2023 | 546,303.00 |
| Oct 31, 2022 | 742,001.00 |
| Jul 31, 2022 | 587,542.00 |
| Apr 30, 2022 | 349,723.00 |
| Jan 31, 2022 | 638,827.00 |
| Oct 31, 2021 | 928,204.00 |
| Jul 31, 2021 | 349,723.00 |